Highest-materiality recent filing
BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12
Q1 net sales $1.378B (-3% YoY); GAAP EPS $0.90, adjusted EPS $0.32 (beating guidance).
BBWI Q4 adj EPS $2.05 beats; FY2026 sales guide down 2.5-4.5%, adj EPS $2.40-2.65
Q4 net sales $2.724B (-2% YoY); adj EPS $2.05 vs prior year $2.09 but above company guidance.
Bath & Body Works calls for redemption of all outstanding 6.694% Senior Notes due 2027
Notice of redemption for any and all outstanding 6.694% Senior Notes due 2027 (CUSIP unknown).
Bath & Body Works Chief Legal Officer Michael Wu to depart; search underway for successor
Michael Wu ceased as Chief Legal Officer and Corporate Secretary effective February 24, 2026.
Bath & Body Works launches transformation plan; Q3 EPS $0.37, cuts FY25 guidance
Q3 net sales $1.594B (-1% YoY); GAAP EPS $0.37 ($0.35 adj); operating income $161M vs $218M prior year.
BBWI Q2 net sales +1.5% to $1.55B, adj EPS $0.37 (high end); raises FY adj EPS low end
Q2 GAAP EPS $0.30 vs $0.68 last year; adj EPS $0.37 flat YoY.
All nine director nominees elected; Alessandro Bogliolo received 8.6M against votes, lowest support among nominees.
Bath & Body Works Q1 net sales up 3% to $1.42B, EPS up 29% to $0.49; maintains FY guidance
Net sales $1,424M (+2.9% YoY); EPS $0.49 (+29% YoY) vs $0.38 prior year.
Bath & Body Works amends and restates senior secured ABL facility with five-year maturity
Facility matures five years after closing, with springing maturity 91 days prior to certain senior note maturities.
Bath & Body Works names Daniel Heaf CEO; Q1 EPS $0.49 beats high-end guidance
Daniel Heaf appointed CEO effective May 16, 2025, replacing Gina Boswell who stepped down.
Bath & Body Works hosts investor tour at Beauty Park; presentation available online
Investor tour at Beauty Park in Columbus, Ohio on April 17, 2025 at 10 a.m. ET.
CEO Gina Boswell to take temporary absence for scheduled surgery starting March 20
Boswell will be out of the office for up to four weeks starting March 20, 2025, followed by remote work.
Bath & Body Works reaffirms Q1 and FY2025 guidance at BofA conference
Reaffirmed Q1 2025 net sales growth of 1-3% and EPS of $0.36-$0.43 per diluted share.
Bath & Body Works Q4 2024 beats guidance; provides FY2025 outlook
Q4 net sales $2,788M (down 4.3% YoY on 13 vs 14 weeks); GAAP EPS $2.09 vs $2.55.
CHRO Deon Riley leaves Bath & Body Works effective Jan 31, 2025
Deon Riley ceased as Chief Human Resources Officer on Jan 31, 2025.
Bath & Body Works redeems all outstanding 9.375% Senior Notes due 2025 on Jan 30
Notice of redemption for any and all outstanding 9.375% Senior Notes due 2025.
Bath & Body Works Q3 sales up 3% to $1.61B, EPS $0.49 beats guidance; raises FY guidance
Q3 net sales $1,610M (+3% YoY); EPS $0.49 vs $0.52 ($0.48 adjusted) prior year, exceeding guidance.
Julie Rosen steps down as Bath & Body Works President, Retail; role eliminated
Rosen ceased as President, Retail effective Sep 25, 2024; will be advisory until Oct 22 then separate.
Bath & Body Works Q2 adjusted EPS $0.37 beats guidance; lowers FY2024 outlook
Q2 net sales $1,526M, down 2.1% YoY; adjusted EPS $0.37 vs. $0.40 last year, above guidance.
Bylaws amended: advance notice for 2025 annual meeting must be received between Feb 27 and Mar 29, 2025.
Bath & Body Works Q1 EPS $0.38 beats high-end guidance; narrows FY2024 range upward
Q1 net sales $1,384M (-0.9% YoY) above guidance; diluted EPS $0.38 (GAAP), up 9% YoY.
the Board of Directors (the "Board") of the Company approved the appointment of Tom Javitch to serve as the Company’s Interim Chief Financial Officer
Ms. Boratto provided notice of her intent to resign from the Company to pursue another professional opportunity, effective as of the Transition Date, on May 20, 2026.
resigned as a member of the Board effective the same day
the Board of Directors of the Company (the “Board”) has appointed Daniel Heaf to serve as Chief Executive Officer of the Company, effective May 16, 2025
Gina Boswell ceased to serve as Chief Executive Officer of the Company effective as of May 16, 2025
Mr. Heaf will be appointed as a member of the Board effective as of immediately following the conclusion of the Company’s 2025 Annual Meeting of Shareholders
Effective on January 31, 2025, Deon Riley ceased to serve as Chief Human Resources Officer of Bath & Body Works, Inc.
Julie Rosen ceased to serve as President, Retail of Bath & Body Works, Inc. (the “Company”) on September 25, 2024.
Max materiality 0.85 · Median 0.65 · Most common event earnings